Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-07-14

Clinical Trial Update: Transbucal Dexmedetomidine for Prevention of Sevoflurane Emergence Agitation in Pre-school Children [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial update on transbucal dexmedetomidine for preventing sevoflurane emergence agitation in preschool children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Transbucal Dexmedetomidine (dexmedetomidine)

Snippet

Sponsor: Assiut University | Conditions: Agitation | Phase 2, Phase 3 | Status: COMPLETED